U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07395570) titled 'Efficacy of CADe System in Detecting Gastric Neoplasia' on Jan. 30.
Brief Summary: Gastric cancer remains the 5th most common cancers worldwide. It also ranked 5th in the cancer related mortality, causing more than 650'000 deaths per year. Survival of gastric cancer is directly related to the stage of the presentation, with early stage cancers having a significantly better survival. Patients with stage I gastric cancer generally have a 5-year survival of more than 90%. In particular, T1a cancer confined to the mucosa are amenable for endoscopic resection, and patients who underwent such treatment have an excellent survival of 97.2% ...